Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Mar;38(5):546-554.
doi: 10.1089/neu.2020.7055. Epub 2020 Dec 14.

Satisfaction with Life after Mild Traumatic Brain Injury: A TRACK-TBI Study

Collaborators, Affiliations
Observational Study

Satisfaction with Life after Mild Traumatic Brain Injury: A TRACK-TBI Study

Stephanie D Agtarap et al. J Neurotrauma. 2021 Mar.

Abstract

Identifying the principal determinants of life satisfaction following mild TBI (mTBI) may inform efforts to improve subjective well-being in this population. We examined life satisfaction among participants in the Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) study who presented with mTBI (Glasgow Coma Scale [GCS] score = 13-15; n = 1152). An L1-regularization path algorithm was used to select optimal sets of baseline and concurrent symptom measures for prediction of scores on the Satisfaction with Life Scale (SWLS) at 2 weeks and 3, 6, and 12 months post-injury. Multi-variable linear regression models (all n = 744-894) were then fit to evaluate associations between the empirically selected predictors and SWLS scores at each follow-up visit. Results indicated that emotional post-TBI symptoms (all b = -1.27 to -0.77, all p < 0.05), anhedonia (all b = -1.59 to -1.08, all p < 0.01), and pain interference (all b = -1.38 to -0.89, all p < 0.001) contributed to the prediction of lower SWLS scores at all follow-ups. Insomnia predicted lower SWLS scores at 2 weeks, 3 months, and 6 months (all b = -1.11 to -0.83, all ps < 0.01); and negative affect predicted lower SWLS scores at 2 weeks, 3 months, and 12 months (all b = -1.38 to -0.80, all p < 0.005). Other post-TBI symptom domains and baseline socio-demographic, injury-related, and clinical characteristics did not emerge as robust predictors of SWLS scores during the year after mTBI. Efforts to improve satisfaction with life following mTBI may benefit from a focus on the detection and treatment of affective symptoms, pain, and insomnia. The results reinforce the need for tailoring of evidence-based treatments for these conditions to maximize efficacy in patients with mTBI.

Keywords: concussion; life satisfaction; post-concussive symptoms; traumatic brain injury; well-being.

PubMed Disclaimer

Conflict of interest statement

Dr. Mukherjee received grants from GE Healthcare and non-financial support from GE-NFL Head Health Initiative outside the submitted work; in addition, Dr. Mukherjee had a patent for USPTO No. 62/269,778 pending. Dr. Yuh had a patent for USPTO No. 62/269,778 pending. Dr. Manley received grants from the National Institute of Neurological Disorders and Stroke (NINDS) during the conduct of the study; research funding from the U.S. Department of Energy, grants from the Department of Defense, research funding from Abbott Laboratories, grants from the National Football League Scientific Advisory Board, and research funding from One Mind outside the submitted work; in addition, Dr. Manley had a patent for Interpretation and Quantification of Emergency Features on Head Computed Tomography issued. He served for two seasons as an unaffiliated neurological consultant for home games of the Oakland Raiders; he was compensated $1500 per game for six games during the 2017 season but received no compensation for this work during the 2018 season. Dr. Stein has been a paid consultant for Actelion, Aptinyx, Bionomics, Genentech, GW Pharma, Janssen, Neurocrine Biosciences, Nobilis Therapeutics, and Oxeia Biopharmaceuticals outside the submitted work. Dr. Diaz-Arrastia received personal fees and research funding from Neural Analytics, Inc. and travel reimbursement from Brain Box Solutions, Inc. outside the submitted work. Dr. Goldman received personal fees from Amgen, Avanir Pharmaceuticals, Acadia Pharmaceuticals, Aspen Health Strategy Group, and Celgene outside the submitted work. Dr. Kreitzer received personal fees from Portola outside the submitted work. Dr. Rosand received personal fees from Boehringer Ingelheim and New Beta Innovations outside the submitted work. Dr. Zafonte received royalties from Oakstone for an educational CD (Physical Medicine and Rehabilitation: a Comprehensive Review) and Demos publishing for serving as co-editor of Brain Injury Medicine. Dr. Zafonte serves or served on the scientific advisory boards of Myomo, Oxeia Biopharma, Biodirection, and Elminda. In addition, he evaluates patients in the MGH Brain and Body-TRUST Program, which is funded by the National Football League Players Association. Dr. Zafonte also served on the Mackey White Committee.

References

    1. Centers for Disease Control and Prevention. (2015). Report to Congress on traumatic brain injury in the United States: epidemiology and rehabilitation. National Center for Injury Prevention and Control, Division of Unintentional Injury Prevention: Atlanta, GA
    1. Hyder, A.A., Wunderlich, C.A., Puvanachandra, P., Gururaj, G., and Kobusingye, O.C. (2007). The impact of traumatic brain injuries: a global perspective. NeuroRehabilitation 22, 341–353 - PubMed
    1. Corrigan, J.D., Bogner, J.A., Mysiw, W.J., Clinchot, D., and Fugate, L. (2001). Life satisfaction after traumatic brain injury. J. Head Trauma Rehabil. 16, 543–555 - PubMed
    1. Diener, E. (1984). Subjective well-being. Psychol. Bull. 95, 542–575 - PubMed
    1. Fuhrer, M.J. (1994). Subjective well-being: implications for medical rehabilitation outcomes and models of disablement. Am. J. Phys. Med. Rehabil. 73, 358–364 - PubMed

Publication types

MeSH terms